Investment
Features
FeesSafety
Academy
More
Pluang+

Vera Therapeutics reports strong Phase III trial results and early commercial demand for kidney treatment.

Market News
15 Sep 2026
Seeking Alpha
View Source
Bullish
Vera Therapeutics reports strong Phase III trial results and early commercial demand for kidney treatment.

Vera Therapeutics announced positive final results from their pivotal Phase III trial showing significant efficacy in kidney function improvement. About 10 weeks into their first commercial launch, the company has received over 350 patient prescriptions, indicating strong early demand. They plan to present these data at the upcoming ASN kidney conference and aim for full regulatory approval by mid-2027 through a supplemental Biologics License Application (sBLA) submission in Q4 2026. This marks a major milestone for Vera and patients awaiting new kidney treatment options.

Vera Therapeutics' recent pivotal Phase III trial results and early commercial launch are notable alongside the current health sector market snapshot on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Sep 16, 2026 03:25 WIB: out of 91 priced US health-sector stocks, 55 rose and 36 fell. Key movers include TXG (10X Genomics Inc) at USD 74.50 with a +6.26% change, ADMA (ADMA Biologics Inc) at USD 8.58 with a -6.13% change, and AMWL (American Well Corp) at USD 13.76 with a +5.85% change.

More News

New 'BadEngram' attack exposes hidden risks in open-weight AI models' memory components

New 'BadEngram' attack exposes hidden risks in open-weight AI models' memory components

Researchers from Pillar Security and Fujitsu revealed 'BadEngram,' a stealthy supply-chain attack targeting the gated memory components in open-weight AI models like Qwen3.8-Flash-Next and DeepSeek-V4.1-Flash. This attack implants a hidden backdoor b...

Market News
Bearish
1 hour ago
Alm. Brand A/S buys back 1.07 million shares in latest week, holding 3.49% of total shares.

Alm. Brand A/S buys back 1.07 million shares in latest week, holding 3.49% of total shares.

Alm. Brand A/S continued its share buyback program from October 6 to 12, 2026, purchasing 1,067,445 shares at an average price of DKK 16.41 per share. This brings the total shares bought under the program to 16,272,795, with a cumulative spend of abo...

Company Fundamentals
Neutral
1 hour ago
Michelin reports total voting rights and shares as of September 30, 2026, including treasury shares.

Michelin reports total voting rights and shares as of September 30, 2026, including treasury shares.

Michelin has officially declared the total number of voting rights and shares composing its capital as of September 30, 2026. The company reports 687,606,419 shares outstanding, with a theoretical total of 976,500,156 voting rights and 958,851,942 ex...

Company Fundamentals
Neutral
1 hour ago
Michelin reports total voting rights and shares as of September 30, 2026

Michelin reports total voting rights and shares as of September 30, 2026

Michelin disclosed the total number of its shares and voting rights as of September 30, 2026. The company has 687,606,419 shares and 958,851,942 voting rights, accounting for 17,648,214 treasury shares. This disclosure is part of regulatory complianc...

Company Fundamentals
Neutral
1 hour ago
US Rental Business Census 2026 counts 128,188 rental listings, revealing state-by-state rental market insights.

US Rental Business Census 2026 counts 128,188 rental listings, revealing state-by-state rental market insights.

The US Rental Business Census 2026 by Reservety reports 128,188 rental business listings across 12 categories in all US states and D.C., identifying about 114,235 unique businesses with 98,123 independent operators. Wyoming leads with the highest ren...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App